Label: ALENDRONATE SODIUM powder

  • NDC Code(s): 73377-173-01
  • Packager: AX Pharmaceutical Corp
  • Category: BULK INGREDIENT - ANIMAL DRUG
  • DEA Schedule: None
  • Marketing Status: Bulk Ingredient For Animal Drug Compounding

Drug Label Information

Updated November 9, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • Alendronate Sodium

    image description

  • INGREDIENTS AND APPEARANCE
    ALENDRONATE SODIUM 
    alendronate sodium powder
    Product Information
    Product TypeItem Code (Source)NDC:73377-173
    Route of AdministrationNOT APPLICABLE
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ALENDRONATE SODIUM (UNII: 2UY4M2U3RA) (ALENDRONIC ACID - UNII:X1J18R4W8P) ALENDRONATE SODIUM1 g  in 1 g
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73377-173-01100 g in 1 JAR
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    bulk ingredient for animal drug compounding11/09/2022
    Labeler - AX Pharmaceutical Corp (204011316)
    Establishment
    NameAddressID/FEIBusiness Operations
    AX Pharmaceutical Corp204011316relabel, repack
    Establishment
    NameAddressID/FEIBusiness Operations
    Cadila Pharmaceuticals Limited916130698api manufacture
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events (Animal Drug), FDA Safety Recalls (Animal Drug)

Related Resources

Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!